272 related articles for article (PubMed ID: 30973416)
21. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease.
Hanada Y; Khanna S; Loftus EV; Raffals LE; Pardi DS
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):528-533. PubMed ID: 29037938
[TBL] [Abstract][Full Text] [Related]
22. Clostridium difficile infection and inflammatory bowel disease: what gastroenterologists and surgeons should know.
Cojocariu C; Trifan A; Stoica O; Chihaia CA; Stanciu C
Chirurgia (Bucur); 2014; 109(5):579-83. PubMed ID: 25532244
[TBL] [Abstract][Full Text] [Related]
23. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
[TBL] [Abstract][Full Text] [Related]
24. Is Clostridioides difficile toxins detection necessary when the glutamate dehydrogenase enzyme is detected?
García-Fuentes JF; Torres-Murillo BJ; Aguilar-Orozco G; González É; Mosqueda JL; Macías AE; Álvarez JA
Gac Med Mex; 2021; 157(1):107-109. PubMed ID: 34125803
[TBL] [Abstract][Full Text] [Related]
25. A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.
Liu C; Tang C; Han Y; Xu Y; Ni F; Jin K; Liu G
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):345-351. PubMed ID: 32944896
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous Detection of
Yoo IY; Song DJ; Huh HJ; Lee NY
Ann Lab Med; 2019 Mar; 39(2):214-217. PubMed ID: 30430786
[TBL] [Abstract][Full Text] [Related]
27. High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study.
Chen XL; Deng J; Chen X; Wan SS; Wang Y; Cao Q
J Dig Dis; 2019 Sep; 20(9):460-466. PubMed ID: 31278840
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.
Kawada M; Annaka M; Kato H; Shibasaki S; Hikosaka K; Mizuno H; Masuda Y; Inamatsu T
J Infect Chemother; 2011 Dec; 17(6):807-11. PubMed ID: 21725661
[TBL] [Abstract][Full Text] [Related]
29. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of
Zhou Y; Wu Y; Zeng H; Chen C; Xie Q; He L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):998-1003. PubMed ID: 38862459
[TBL] [Abstract][Full Text] [Related]
31. Molecular epidemiology and clinical characteristics of Clostridioides difficile infection in patients with inflammatory bowel disease from a teaching hospital.
Li YM; Liao JZ; Jian ZJ; Li HL; Chen X; Liu QX; Liu PL; Wang ZQ; Liu X; Yan Q; Liu WE
J Clin Lab Anal; 2022 Dec; 36(12):e24773. PubMed ID: 36397282
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon.
Djuikoue IC; Tambo E; Tazemda G; Njajou O; Makoudjou D; Sokeng V; Wandji M; Tomi C; Nanfack A; Dayomo A; Lacmago S; Tassadjo F; Sipowo RT; Kakam C; Djoko AB; Assob CN; Andremont A; Barbut F
Infect Dis Poverty; 2020 Aug; 9(1):122. PubMed ID: 32867842
[TBL] [Abstract][Full Text] [Related]
34. Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: A single-center retrospective study of 260 cases in China.
Gu YB; Zhang MC; Sun J; Lv KZ; Zhong J
J Dig Dis; 2017 Apr; 18(4):207-211. PubMed ID: 28251812
[TBL] [Abstract][Full Text] [Related]
35. [Infection rate and clinical characteristics of toxigenic
Li D; Guo S; Guan DX; Zhao CN; Xu XW
Zhonghua Er Ke Za Zhi; 2020 Jul; 58(7):564-569. PubMed ID: 32605340
[No Abstract] [Full Text] [Related]
36. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease.
Stoica O; Trifan A; Cojocariu C; Gîrleanu I; Maxim R; Stanciu MC
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):81-6. PubMed ID: 25970947
[TBL] [Abstract][Full Text] [Related]
37. Testing for Clostridium difficile in patients newly diagnosed with inflammatory bowel disease in a community setting.
Krishnarao A; de Leon L; Bright R; Moniz H; Law M; Leleiko N; Sands BE; Merrick M; Shapiro J; Wallenstein S; Giacalone J; Shah SA
Inflamm Bowel Dis; 2015 Mar; 21(3):564-9. PubMed ID: 25581825
[TBL] [Abstract][Full Text] [Related]
38. Management of inflammatory bowel disease with
D'Aoust J; Battat R; Bessissow T
World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
[TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
40. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
Li Y; Qian J; Queener E; Shen B
Inflamm Bowel Dis; 2013 Feb; 19(2):397-403. PubMed ID: 23328770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
